Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Billionaire Ken Griffin’s Top 5 High Dividend Stock Picks

In this article, we discuss billionaire Ken Griffin’s top 5 high-dividend stock picks. If you want to read our detailed analysis of Ken Griffin’s investment strategy, go directly to read Billionaire Ken Griffin’s Top 10 High Dividend Stock Picks

5. Citigroup Inc. (NYSE:C)

Citadel Investment Group’s Stake Value: $188,051,776
Dividend Yield as of February 17: 3.98%

Citigroup Inc. (NYSE:C) is a New York-based multinational investment bank and financial services company that serves over 200 million customers in more than 160 countries. In January, BofA raised its price target on the stock to $60 with a Buy rating on the shares, highlighting the company’s efforts to build capital and execute its consumer business.

At the end of Q4 2022, Citadel Investment Group owned over 4.1 million shares of Citigroup Inc. (NYSE:C), worth over $188 million. The hedge fund raised its position in the company by 81% during the quarter. The company made up 0.04% of the firm’s 13F portfolio.

On January 12, Citigroup Inc. (NYSE:C) declared a quarterly dividend of $0.51 per share, which fell in line with its previous dividend. The stock has a dividend yield of 3.98%, as of February 17. It is among the top high-dividend stock picks of billionaire Ken Griffin.

At the end of Q3 2022, 85 hedge funds tracked by Insider Monkey reported owning stakes in Citigroup Inc. (NYSE:C), growing from 82 in the previous quarter. These stakes are worth over $7.1 billion collectively.

Diamond Hill Capital mentioned Citigroup Inc. (NYSE:C) in its Q1 2022 investor letter. Here is what the firm has to say:

“Shares of Citigroup declined in the quarter as investors became increasingly negative on capital markets activity. The company is also continuing to divest certain consumer banking geographies which may be dilutive to earnings in the near term.”

Follow Citigroup Inc (NYSE:C)

4. Bristol-Myers Squibb Company (NYSE:BMY)

Citadel Investment Group’s Stake Value: $221,573,766
Dividend Yield as of February 17: 3.21%

Bristol-Myers Squibb Company (NYSE:BMY) is an American multinational pharmaceutical company that provides innovative medical solutions to its patients. On December 8, the company declared a 5.6% hike in its quarterly dividend to $0.57 per share. This was the company’s 17th consecutive year of dividend growth, which makes it one of the top high-dividend stock picks of billionaire Ken Griffin. The stock’s dividend yield on February 17 came in at 3.21%.

In January, Cantor Fitzgerald initiated its coverage of Bristol-Myers Squibb Company (NYSE:BMY) with an Overweight rating and a $95 price target. The firm mentioned that the company has one of the best growth profiles in the US pharma group for 2023.

In Q4 2022, Citadel Investment Group raised its position in Bristol-Myers Squibb Company (NYSE:BMY) by 1,285%, which takes its total BMY stake to over $221.5 million. The company represented 0.05% of the firm’s 13F portfolio.

At the end of Q3 2022, 68 hedge funds in Insider Monkey’s database owned stakes in Bristol-Myers Squibb Company (NYSE:BMY), with a total value of over $1.7 billion.

Baron Funds mentioned Bristol-Myers Squibb Company (NYSE:BMY) in its Q2 2022 investor letter. Here is what the firm has to say:

“We established a position in Bristol-Myers Squibb Company, a global biopharmaceutical company focused on discovering, developing, and selling medicines for patients in the therapeutic areas of oncology, immunology, cardiovascular, and neurology. The stock trades at a low valuation relative to its current earnings because the company faces loss of exclusivity on several key drugs over the next eight years, including Revlimid, Eliquis, and Opdivo.

At the same time, Bristol-Myers has multiple new products in the early stages of launch (e.g., Opdualag, Camzyos, Breyanzi, and Reblozyl), a robust new product pipeline (e.g., Deucravacitinib, Milvexian, and CELMoD agents), and a strong balance sheet combined with strong free cash flow generation that the company can use for acquisitions. Management believes these growth drivers can more than offset the loss of exclusivity and drive revenue growth through the end of the decade. Given the company’s low valuation, if the company can execute, we think there is substantial upside in the stock.”

Follow Bristol Myers Squibb Co (NYSE:BMY)

3. Cisco Systems, Inc. (NASDAQ:CSCO)

Citadel Investment Group’s Stake Value: $223,259,001
Dividend Yield as of February 17: 3.08%

Cisco Systems, Inc. (NASDAQ:CSCO) is an American multinational digital communications company, based in California. In February, Loop Capital raised its price target on the stock to $66 with a Buy rating on the shares, appreciating the company’s recent quarterly earnings. The firm also highlighted the company’s ‘decade-high’ revenue growth.

Cisco Systems, Inc. (NASDAQ:CSCO) is one of the top high-dividend stock picks of billionaire Ken Griffin as the hedge fund owned over 4.6 million shares in the company, worth $223.2 million. The company represented 0.05% of Citadel’s 13F portfolio.

On February 15, Cisco Systems, Inc. (NASDAQ:CSCO) hiked its quarterly dividend by 1 cent to $0.39 per share. Through this increase, the company took its dividend growth streak to 12 years. As of February 17, the stock has a dividend yield of 3.08%.

Cisco Systems, Inc. (NASDAQ:CSCO) was a part of 68 hedge fund portfolios in Q3 2022, compared with 63 in the previous quarter, as per Insider Monkey’s database. The stakes owned by these hedge funds have a total value of over $2.78 billion.

Carillon Tower Advisers mentioned Cisco Systems, Inc. (NASDAQ:CSCO) in its Q1 2022 investor letter. Here is what the firm has to say:

Cisco Systems (NASDAQ:CSCO) traded lower as investors weighed how supply chain concerns would impact sales growth. The company has been upgrading its switching and routing offerings, which should lead to strong demand as on-site locations upgrade infrastructure.”

Follow Cisco Systems Inc. (NASDAQ:CSCO)

2. Broadcom Inc. (NASDAQ:AVGO)

Citadel Investment Group’s Stake Value: $238,323,572
Dividend Yield as of February 17: 3.10%

Broadcom Inc. (NASDAQ:AVGO) is another top high-dividend stock pick of billionaire Ken Griffin. The semiconductor company has been raising its payouts consistently for the past 12 years. It pays a quarterly dividend of $4.60 per share and has a dividend yield of 3.10%, as recorded on February 17.

At the end of Q4 2022, Citadel Investment Group owned over $238.3 million worth of stakes in Broadcom Inc. (NASDAQ:AVGO). The company made up 0.05% of the firm’s 13F portfolio.

The number of hedge funds tracked by Insider Monkey owning stakes in Broadcom Inc. (NASDAQ:AVGO) grew to 74 in Q3 2022, from 66 in the previous quarter. The collective value of these stakes is over $4.4 billion.

Carillon Tower Advisers mentioned Broadcom Inc. (NASDAQ:AVGO) in its Q2 2022 investor letter. Here is what the firm has to say:

“Tech stocks, including Broadcom Inc. (NASDAQ:AVGO), were one of the hardest-hit sectors due to fears over a weakening macroeconomic environment. Broadcom, however, outperformed semiconductor peers as its end-market exposures provided relatively more defensive characteristics.”

Follow Broadcom Inc. (NASDAQ:AVGO)

1. U.S. Bancorp (NYSE:USB)

Citadel Investment Group’s Stake Value: $296,388,126
Dividend Yield as of February 17: 3.97%

U.S. Bancorp (NYSE:USB) is a Minnesota-based financial services company. At the end of Q4 2022, Citadel Investment Group owned nearly 6.8 million shares in the company, worth over $296.3 million. The company accounted for 0.06% of the firm’s 13F portfolio. The hedge fund has been investing in the company since the fourth quarter of 2010.

U.S. Bancorp (NYSE:USB), one of the top high-dividend stock picks of billionaire Ken Griffin, currently pays a quarterly dividend of $0.48 per share. The stock’s dividend yield on February 17 came in at 3.97%, as of February 17. It has been rewarding shareholders with growing dividends for the past 12 years.

At the end of Q3 2022, elite funds remained bullish on U.S. Bancorp (NYSE:USB), with hedge fund positions increasing to 52, from 43 in the previous quarter, as per Insider Monkey’s database. The stakes owned by these hedge funds have a total value of roughly $4.8 billion.

Follow Us Bancorp (NYSE:USB)

You can also take a look at Analysts Are Downgrading These Stocks and 10 Best Long-Term Stocks To Buy According to Buffett

Follow Insider Monkey on Twitter

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.